Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

about

Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

Item

http://www.wikidata.org/entity/Q38826017

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

@en

type

Item

label

Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

@en

prefLabel

Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

@en

P1476

Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

@en

P2093

Angela Wateska

http://www.w3.org/2001/XMLSchema#string

Eunha Shim

http://www.w3.org/2001/XMLSchema#string

Jay V DePasse

http://www.w3.org/2001/XMLSchema#string

Jonathan M Raviotta

http://www.w3.org/2001/XMLSchema#string

Kenneth J Smith

http://www.w3.org/2001/XMLSchema#string

Richard K Zimmerman

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccines for preventing influenza in healthy children

Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014.

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.

Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment

Rates of pneumococcal disease in adults with chronic medical conditions.

Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials.

P31

scholarly article

P356

10.1016/J.AMEPRE.2017.02.019

http://www.w3.org/2001/XMLSchema#string

P50

Shawn T. Brown

Mary Patricia Nowalk

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28431811

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

5610050

http://www.w3.org/2001/XMLSchema#string